Large contribution of human papillomavirus in vaginal neoplastic lesions: A worldwide study in 597 samples

European Journal of Cancer

Volumn 50, Issue 16, 2014, Pages 2846-2854

  Alemany, L ^a,b   Saunier, M ^a   Tinoco, L ^c   Quiros B ^a   Alvarado Cabrero, I ^d   Alejo, M ^a,e   Joura, E A ^f   Maldonado, P ^g   Klaustermeier, J ^a,b   Salmeron J ^d   Bergeron, C ^h   Petry, K U ⁱ   Guimera N ^j   Clavero, O ^a   Murillo, R ^k   Clavel, C ^l,m   Wain, V ⁿ   Geraets, D T ^j   Jach, R ^o   Cross, P ^p   Carrilho, C ^q   Molina, C ^r   Shin, H R ^s   Mandys, V ^t   Nowakowski, A M ^u   Vidal, A ^a   Lombardi, L ^v   Kitchener, H ^w   Sica, A R ^x   Magana Leon C ^y   Pawlita, M ^z   Quint, W ^j   Bravo, I G ^a   Munoz N ^k   De Sanjose S ^a,b   Bosch, F X ^a   more..

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Hospital Oncologico SOLCA   (Ecuador)

^d HOSPITAL DE ONCOLOGÍA   (Mexico)

^e HOSPITAL GENERAL DE CATALUNYA   (Spain)

^f UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h LABORATOIRE CERBA   (France)

ⁱ Klinikum Wolfsburg   (Germany)

^j Manager Development and Diagnostic Services (DDS)   (Netherlands)

^k Instituto Nacional de Cancerología   (Colombia)

^l HÔPITAL MAISON BLANCHE   (France)

^m INSERM   (France)

ⁿ WESTMEAD HOSPITAL   (Australia)

^o JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^p Queen Elizabeth Hospital   (United Kingdom)

^q EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^r UNIVERSITY OF CHILE   (Chile)

^s National Cancer Center   (South Korea)

^t CHARLES UNIVERSITY   (Czech Republic)

^u MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^v Hospital General San Juan de Dios   (Guatemala)

^w MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^x Laboratorio de Anatomia Patológica Del Hospital de la Mujer   (Uruguay)

^y INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^z GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

Human papillomavirus; Keywords Vaginal cancer; Vaccine; Vaginal intraepithelial neoplasia

Indexed keywords

VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AFRICA; AGED; ARTICLE; ASIA; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EUROPE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 30; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 89; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; PACIFIC ISLANDS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR INVASION; VAGINA CANCER; VAGINAL INTRAEPITHELIAL NEOPLASIA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TRANSFORMATION; WART VIRUS; WESTERN HEMISPHERE; CARCINOMA, SQUAMOUS CELL; COMPLICATION; CROSS-SECTIONAL STUDY; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; METABOLISM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; POISSON DISTRIBUTION; PRECANCEROUS CONDITIONS; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VAGINAL NEOPLASMS; VIROLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOENZYME TECHNIQUES; INTERNATIONAL COOPERATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POISSON DISTRIBUTION; PRECANCEROUS CONDITIONS; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 84922642209     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.07.018     Document Type: Article

References (28)

1. C. de Martel, J. Ferlay, S. Franceschi, J. Vignat, F. Bray, and D. Forman Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
2. Tumours of the vagina. In: Tavassoli FA, Devilee P, editors. World Health Organization: tumours of the breast and female genital organs (Who/IARC Classification of Tumours) (IARC WHO Classification of Tumours). The International Agency for Research on Cancer; 2003. 272. p. 291-312 [chapter 6].
3. V. Lilic, G. Lilic, S. Filipovic, M. Visnjic, and R. Zivadinovic Primary carcinoma of the vagina J BUON 15 2 2010 241 247
4. A.E. Grulich, M.T. van Leeuwen, M.O. Falster, and C.M. Vajdic Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 9581 2007 59 67
5. K. Hellman, C. Silfverswärd, B. Nilsson, A.C. Hellström, B. Frankendal, and F. Pettersson Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956-96 Int J Gynecol Cancer 14 3 2004 491 501
6. J.R. Daling, M.M. Madeleine, S.M. Schwartz, K.A. Shera, J.J. Carter, and B. McKnight A population-based study of squamous cell vaginal cancer: HPV and cofactors Gynecol Oncol 84 2 2002 263 270
7. A.L. Herbst, H. Ulfelder, and D.C. Poskanzer Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women N Engl J Med 284 15 1971 878 881
8. R. Mittendorf Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero Teratology 51 6 1995 435 445
9. P.E. Treffers, A.G. Hanselaar, T.J. Helmerhorst, M.E. Koster, and F.E. van Leeuwen Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem Ned Tijdschr Geneeskd 145 14 2001 675 680
10. J.J. Carter, M.M. Madeleine, K. Shera, S.M. Schwartz, K.L. Cushing-Haugen, and G.C. Wipf Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites Cancer Res 61 5 2001 1934 1940
11. B.S. Madsen, H.L. Jensen, A.J. van den Brule, J. Wohlfahrt, and M. Frisch Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark Int J Cancer 122 12 2008 2827 2834
12. H. De Vuyst, G.M. Clifford, M.C. Nascimento, M.M. Madeleine, and S. Franceschi Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 7 2009 1626 1636
13. N. Li, S. Franceschi, R. Howell-Jones, P.J. Snijders, and G.M. Clifford Humanpapillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication Int J Cancer 128 4 2011 927 935
14. S. de Sanjose, W.G. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, and B. Lloveras Retrospective international survey and HPV time trends study group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 11 2010 1048 1056
15. B. Kleter, L.J. van Doorn, J. ter Schegget, L. Schrauwen, K. van Krimpen, and M. Burger Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses Am J Pathol 153 6 1998 1731 1739
16. B. Kleter, L.J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, and J. ter Schegget Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus J Clin Microbiol 37 8 1999 2508 2517
17. A review of human carcinogens. Part B: Biological agents/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2009: Lyon, France).
18. D. Geraets, L. Alemany, N. Guimera, S. de Sanjose, M. de Koning, and A. Molijn Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer J Pathol 19 2012 4065 10.1002/path
19. R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U. Petry, G. Dallenbach-Hellweg, D. Schmidt, and M. von Knebel Doeberitz Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 2001 276 284
20. G. Halec, D. Holzinger, M. Schmitt, C. Flechtenmacher, G. Dyckhoff, and B. Lloveras Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma Br J Cancer 109 2013 172 183
21. A.J. Barros, and V.N. Hirakata Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio BMC Med Res Method 3 2003 21
22. A.K. Sinno, M. Saraiya, T.D. Thompson, B.Y. Hernandez, M.T. Goodman, M. Steinau, M. Watson, C. Lyu, and E.R. Unger Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population Obstet Gynecol 123 4 2014 817 821
23. S. de Sanjosé, L. Alemany, J. Ordi, S. Tous, M. Alejo, and S.M. Bigby HPV VVAP study group. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva Eur J Cancer 49 16 2013 3450 3461
24. P. Guan, R. Howell-Jones, N. Li, L. Bruni, S. de Sanjosé, and S. Franceschi Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer Int J Cancer 131 10 2012 2349 2359
25. A.R. Kreimer, G.M. Clifford, P. Boyle, and S. Franceschi Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2 2005 467 475
26. J. Verloop, F.E. van Leeuwen, T.J. Helmerhorst, H.H. van Boven, and M.A. Rookus Cancer risk in DES daughters Cancer Causes Control 21 7 2010 999 1007
27. R.H. Verheijen, J. Verloop, and T.J. Helmerhorst DES Daughter-expertise remains necessary Ned Tijdschr Geneeskd 157 52 2013 A6809
28. P.F. Kaminski, and R.C. Maier Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure Obstet Gynecol 62 6 1983 720 727